MedPath
NMPA Approval

Valsartan and Amlodipine Tablets(I)

国药准字H20249724

December 10, 2024

Drug Information

缬沙坦氨氯地平片(Ⅰ)

片剂

每片含缬沙坦80mg,氨氯地平5mg。

化学药品

December 10, 2024

Company Information

Applicant Company

湖北省安陆市碧涢路137号

Manufacturing Company

湖北省安陆市碧涢路137号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

缬沙坦氨氯地平片(Ⅰ) - NMPA 批准文号 | MedPath